Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate Capsule, Extended Release
Product Images NDC 63629-1973

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate (NDC 63629-1973). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Image 01)

A pharmacokinetic graph showing mean plasma concentrations of dextroamphetamine and levoamphetamine over 24 hours. The curve compares extended-release capsules 20 mg once daily with 10 mg tablets twice daily for both dextroamphetamine and levoamphetamine. Time (hours) is on the x-axis and concentration (ng/mL) on the y-axis.*

FDA Label Image

Label (Lbl636291973)

Label for Dextroamphetamine Sulf-Saccharate/Amphetamine Sulf-Aspartate extended-release capsules, USP 10 mg strength, distributed by Bryant Ranch Prepack. The label shows NDC 63629-1973-1 and indicates the package contains 100 capsules. Manufacturer is UPM Pharmaceuticals, Inc. The label includes the active ingredients' amounts per capsule and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.